Iovance Biotherapeutics, Inc. (IOVA)
3.69
-0.18
(-4.65%)
USD |
NASDAQ |
Mar 20, 16:00
3.73
+0.04
(+1.08%)
After-Hours: 20:00
Iovance Biotherapeutics Research and Development Expense (Quarterly) : 71.20M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Orthofix Medical, Inc. | 15.37M |
| InfuSystem Holdings, Inc. | -- |
| Axogen, Inc. | 12.38M |
| KalVista Pharmaceuticals, Inc. | 11.99M |
| Lantheus Holdings, Inc. | 47.48M |